Wormentel 500 mg is a veterinary antiparasitic medicine containing fenbendazole, an anthelmintic used to control certain parasitic worm infections in animals. It is available as a tablet and is commonly associated with the treatment of gastrointestinal parasites, including roundworms, hookworms, whipworms, and certain tapeworms.
Fenbendazole works against susceptible parasites by interfering with processes they need to absorb nutrients and maintain normal cellular function. By reducing the parasite's ability to survive and grow, the medicine helps control worm infections in susceptible animals.
Kachhela Medex Pvt. Ltd. is identified as the manufacturer/marketer associated with Wormentel 500 mg. Available product information lists fenbendazole as the active ingredient and a strength of 500 mg.
Wormentel 500 mg should be considered a veterinary product. It should not be presented as a human deworming medicine or used by people unless a qualified healthcare professional specifically determines that an appropriate, approved product is suitable.
The appropriate dose of Wormentel 500mg depends on the animal species, body weight, type of parasite, severity of infection, and veterinary treatment plan.
Do not assume that one tablet is the correct dose for every animal. A veterinarian should determine the appropriate amount and treatment duration.
Give the tablet according to the directions provided by the veterinarian or product labeling. Depending on the animal and treatment plan, the tablet may be administered directly or with food.
Do not crush, split, or alter the tablet unless the veterinarian confirms that doing so is appropriate.
Follow the treatment schedule recommended by the veterinarian. Maintaining the recommended dosing interval is important for effective parasite control.
Complete the treatment for the period recommended by the veterinarian. Do not extend treatment or repeat courses unnecessarily.
Prolonged or extralabel use of fenbendazole has been associated with adverse events in dogs, including reports of bone marrow hypoplasia and pancytopenia.
Wormentel 500mg contains fenbendazole, which acts on the cellular structure of susceptible parasites.
Fenbendazole binds to parasite beta-tubulin and interferes with microtubule formation. Microtubules are essential for several functions within parasite cells, including maintaining cell structure and supporting nutrient uptake.
When this process is disrupted, the parasite's ability to obtain and use nutrients is impaired. This affects its energy metabolism and normal cellular activity, eventually contributing to the death or elimination of susceptible parasites.
Because fenbendazole has activity against several types of parasitic worms, it is used as a broad-spectrum veterinary anthelmintic. However, its effectiveness depends on the parasite species and animal being treated.
Pregnant or lactating animals should receive fenbendazole only when recommended by a veterinarian. The veterinarian can determine whether treatment is appropriate based on the animal and the specific infection.
Tell the veterinarian about any existing liver, kidney, gastrointestinal, or other health problems before treatment begins. The treatment plan may need to be adjusted according to the animal's condition.
Extra care may be necessary when treating young, elderly, underweight, or sick animals. The appropriate dose should be calculated according to the animal's species and body weight.
Worm infections can involve different parasite species, and not every antiparasitic medicine works against every parasite. A veterinary diagnosis can help identify the appropriate treatment.
This does not mean that these medicines will always cause an interaction. The veterinarian should assess the animal's complete treatment plan before combining medicines.
Wormentel 500 mg is used in veterinary medicine to control susceptible parasitic worm infections. Fenbendazole products are used in animals including dogs and other veterinary species, depending on the specific product, parasite, and veterinary recommendation. FDA information confirms approved fenbendazole products are available for animal use.
There is no single dosage that is appropriate for every animal. The treatment schedule should be based on the animal's species, weight, parasite being treated, and the specific veterinary product.
Some fenbendazole treatment regimens may involve administration over consecutive days, but the exact schedule should come from the product label or veterinarian.
Do not use a fixed "one tablet for three days" schedule for every animal without veterinary confirmation.
The expected result depends on the parasite, animal species, severity of infection, and correct treatment.
Possible adverse effects can include:
Keep Wormentel 500 in its original packaging and follow the storage instructions provided on the product label.
Store the tablets in a cool, dry place away from direct sunlight and excessive moisture.
Do not use tablets that are damaged, contaminated, or past their stated expiry date.
Wormentel 500 mg contains fenbendazole and is a veterinary antiparasitic product used to control susceptible worm infections in animals.
Wormentel 500 mg should not be described or marketed as a general human deworming medicine. Fenbendazole products are used in veterinary medicine, and human use should not be assumed from veterinary indications. FDA guidance distinguishes medicines approved for animals from medicines approved for people.
The appropriate age, dose, and treatment schedule depend on the animal, product labeling, and parasite being treated. A veterinarian should determine whether fenbendazole is appropriate for a young animal.
The response depends on the parasite, animal, infection level, and treatment schedule. Do not rely on a fixed number of days to judge treatment success. Follow the veterinarian's instructions and seek further advice if symptoms continue.
Long-term or repeated treatment should only be carried out under veterinary supervision. Extra-label or prolonged use of fenbendazole has been associated with serious adverse events in dogs.
Fenbendazole should not be presented as an established cancer treatment for humans. Its established use is as a veterinary anthelmintic, and claims that it is a proven human cancer treatment should be avoided.
| Pack Size | Price |
|---|---|
| 100 Tablet/s | $45.00 |
| 200 Tablet/s | $78.00 |
| 300 Tablet/s | $106.00 |
Medical Disclaimer: The information on this site is for educational purposes only. Consult a licensed healthcare professional before starting, stopping, or changing any medication.
Reviews
There are no reviews yet.